At least six young, high-tech Cincinnati health care companies got face-to-face with the venture capital community at the recent MidAmerica Healthcare Venture Forum, an event that brought more than 400 venture capitalists, bioscience entrepreneurs and experts under one roof in Cincinnati. It's the Midwest's largest annual event showcasing biotech, pharmaceutical, medical-device and industrial biotech companies.
Cincinnati ventures making their pitches to the money people and others were Akebia Pharmaceuticals, a vascular biology form that has licensed assets from P&G Pharmaceuticals; PDS Biotechnology Corp., which is using nanoparticle technology to find therapies to treat cancer; AssureRx, which has developed genetic testing technology so medications can be personalized; CH Mack Inc., which propvides electronic software for handling medical records; Bexion Pharmaceuticals, which is developing targeted therapies to treat cancer; Ausio Pharmaceuticals, which is developing medications for the aged.
The two-day forum earlier this month was a platform to showcase health care start-up companies from across the Midwest that are looking to raise private equity funding.
Writer: David Holthaus
Source: MidAmerica Healthcare Venture Forum
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.